Clinical Trial Update: A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating LY2148568 for glucose control, safety, and tolerability in Japanese patients with Type 2 diabetes; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY2148568

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED